This inventor holds 1 USPTO granted patent. Top assignee: Shockwave Medical, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hester Chan - Innovator in Medical Technology
Introduction
Hester Chan is a notable inventor based in Santa Clara, CA (US). She has made significant contributions to the field of medical technology, particularly in the design of catheters for treating vascular lesions. Her innovative approach has the potential to enhance treatment outcomes for patients with calcified lesions and occlusions.
Latest Patents
Hester Chan holds a patent for an "Electrode design for directional lithotripsy catheters." This patent describes a catheter designed to treat lesions in a body lumen, such as calcified lesions and occlusions in vasculature. The catheter features a dual-layer electrode assembly that includes a first conductive sheath and a second conductive sheath arranged circumferentially around it. When a voltage is applied across these conductive sheaths, current flows across an arcing region, producing shock waves and cavitation bubbles. The design aims to increase the lifespan of the electrode assembly by shaping the distal side edges of the sheaths to promote erosion in a controlled manner.
Career Highlights
Hester Chan is currently employed at Shockwave Medical, Inc., where she continues to develop innovative medical devices. Her work focuses on improving catheter technology, which is crucial for effective treatment in various medical procedures.
Collaborations
Hester collaborates with Anna-Elodie Kerlo, who is also involved in the development of medical technologies. Their partnership enhances the innovation process at Shockwave Medical, Inc.
Conclusion
Hester Chan's contributions to medical technology, particularly through her patented catheter design, demonstrate her commitment to improving patient care. Her work at Shockwave Medical, Inc. continues to pave the way for advancements in the treatment of vascular lesions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
